Perceptive Advisors LLC Purchases New Position in Danaher Corporation $DHR

Perceptive Advisors LLC purchased a new stake in Danaher Corporation (NYSE:DHR) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 200,000 shares of the conglomerate’s stock, valued at approximately $45,784,000.

Other large investors have also made changes to their positions in the company. Elevated Capital Advisors LLC bought a new stake in shares of Danaher in the 4th quarter valued at approximately $26,000. Hilton Head Capital Partners LLC bought a new stake in shares of Danaher in the 4th quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd grew its stake in shares of Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares in the last quarter. JPL Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter valued at approximately $25,000. Finally, WFA of San Diego LLC acquired a new stake in Danaher in the 2nd quarter worth approximately $26,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on DHR. DZ Bank began coverage on Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price for the company. JPMorgan Chase & Co. reduced their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Morgan Stanley reduced their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price for the company. Finally, Barclays reduced their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $233.61.

Danaher Stock Down 1.9%

DHR opened at $177.85 on Thursday. The business has a 50 day moving average price of $180.26 and a 200 day moving average price of $203.59. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The firm has a market cap of $125.88 billion, a P/E ratio of 34.40, a price-to-earnings-growth ratio of 2.31 and a beta of 0.81.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the previous year, the company earned $1.88 earnings per share. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. Research analysts forecast that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s payout ratio is 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.